COVID-19 Vaccine Development, Immunity and Protection in NHP: Anticipating a Moving Target

Daniel Douek, MD, PhD
Principal Investigator / Chief
Human Immunology Section
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, MD, USA

This conference is hosted by Emilia Liana Falcone, MD, PhD. This conference is part of the 2022-2023 IRCM conference calendar.

In person: 
IRCM Auditorium
110, avenue des Pins O, H2W 1R7 Montreal

Online:
Zoom Link : https://zoom.us/j/95269762104
ID : 952 6976 2104
Code : 476372

IRCM conferences are set to occur under a hybrid format. However, please note that last-minute changes to online-only lectures may occur due to unforeseen circumstances. We invite you to visit this webpage again a few days before attending.

About Daniel Douek
Dr. Daniel Douek is a Senior Investigator and Chief of the Human Immunology Section at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. He is also Chief of the Genome Analysis Core and Director of the PREMISE pandemic preparedness program. He also holds the position of Adjunct Professor at the Department of Pathology of the University of Pennsylvania. 

Dr. Douek studies the processes that determine the course of human infectious diseases in which the immune system plays a central role in their pathogenesis and outcome. These include HIV, SARS-CoV-2 and other diseases of pandemic potential. His particular interests lie in inflammation and immune reconstitution, the microbiome and mucosal immunology, antigen-specific adaptive immune responses, and host genetic factors of disease susceptibility and progression. He aims to use the knowledge gained to develop new therapeutic and vaccine approaches. In 2021, Dr. Douek launched the PREMISE pandemic preparedness initiative at the Vaccine Research Center. His work has been published in close to 400 peer-reviewed papers, in several high-impact journals. He has been in the top 1% most-cited researchers in their respective fields since 2014 and has an h-index of 100.
Dr. Douek has received several prestigious distinctions over the years. In 2005, he was named one of the Scientific American 50, an award that honors 50 individuals and organizations whose accomplishments in research and other areas demonstrate outstanding scientific and technological leadership that improves the way we live and offers the greatest hope for the future. The magazine’s board of editors selected Dr. Douek for his contributions in clarifying how HIV infection causes disease and mortality. He was given the World AIDS day Award in 2007 and was named as one of the POZ 100 in 2012, an elite group of scientists, researchers, advocates, politicians and celebrities who are recognized by POZ Magazine for their significant contributions to speeding up the end of AIDS. In 2021, he received NIH Director’s Award for outstanding efforts in the pursuit of efficacious vaccines to prevent COVID-19.

To make sure you don't miss any of the IRCM conferences, sign up now for our newsletter!